Career Development Program: Special Fellow (2- & 3-Year Awards)

Leukemia & Lymphoma Society


Grant amount: US $67,000

Next anticipated deadline: Sep 1, 2019 12:00pm PDT (Letter of inquiry)

Later anticipated deadlines: Sep 15, 2019 12:00pm PDT (Pre proposal), Oct 3, 2019 12:00pm PDT (Full proposal)

Applicant type: Postdoctoral Researcher Faculty Working Professional

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Degree requirements: Applicants must be within 4 years of receiving their PhD

View website    Save Need help writing this grant?

Overview:

Note: The application process is in three phases.

  • Eligibility Phase application is due Sept. 1 ('Letter of Inquiry'). 
    • Applicants whose eligibility is rejected may resubmit for eligibility determination two more times during this application cycle if there is more information to present and if submitted prior to the Eligibility Phase deadline. 
  • If notified as eligible, Abstract submission is due Sept. 15 ('Pre-proposal').
  • If approved, Full Application submission is due Oct. 3 ('Full proposal').

About the Leukemia & Lymphoma Society, Inc.

The Leukemia & Lymphoma Society, Inc. (LLS) is a national voluntary health agency dedicated to the conquest of hematologic malignancies and relevant premalignant conditions. LLS supports research, patient aid, community service programs, advocacy, and public and professional education.

Description of Awards

Through the Career Development Program, LLS supports talented blood cancer researchers in the early phase of their careers. CDP continues to provide a pool of dedicated researchers to advance the understanding and diagnosis of cancer, as well as the development of treatment and prevention options that will ultimately lead to cures for blood cancer patients.

CDP funding is limited to salary support for the applicant, but may be supplemented by funds from other appropriate sources as determined by the Grantee’s Sponsoring Institution. Support for research-associated costs must be provided by another source.

The Special Fellow Award

The award is for 2 or 3 years depending on eligibility. The maximum award per year is $67,000 and includes the applicant’s salary and fringe benefits. Indirect costs may be included, and cannot exceed 5% of the total direct costs requested in the proposal. The final value of the Award may be limited by the applicant’s Sponsoring Institution’s salary range. The awarded value will be limited to the amount requested in the submitted proposal. It is anticipated that the proposed research will occupy a majority of the applicant’s research time. However, there are no requirements for a certain percent effort in our budget template.

Blood Cancer Relevance

LLS encourages scientists of various disciplines to ask questions relevant to hematologic malignancies and/or relevant premalignant conditions/states. Relevance is determined by the experimental approach. Correlation of a biological phenomenon with blood cancer is not sufficient evidence of relevance to LLS’s Mission, unless there are experiments to directly address this correlation. The proposed experiments must seek to answer questions about blood cancer or normal blood cell function of relevance to cancer. There must also be funding support for this research (see Research Support Requirement section).

The intent of LLS’s Fellow Award is to encourage early stage scientists to pursue a career in blood cancer. Thus, the experimental plan and the career trajectory must indicate this desire. LLS also encourages applicants with diverse scientific training to pursue careers in blood cancer. Therefore, Fellow applicants who have little to no blood cancer training are encouraged to apply if they propose relevant experiments in an appropriate Sponsor’s laboratory and have a career plan appropriate for a career in the blood cancer field. 

You can learn more about this opportunity by visiting the funder's website.

Eligibility:

  • Citizenship: LLS welcomes applications from US citizens and non-US-citizens, as well as applicants who are performing research outside the United States.
  • Degree: Applicants must hold a PhD, MD, DVM, or equivalent degree
  • Applicants:
    • Must be between 2 and 4.5 years of the oral thesis defense as of January 1, 2018.
      • Time in clinical training does not count towards this time for eligibility purposes.
      • See the Experience/Eligibility Clock section of "Guidelines & Instructions" document for more details.
    • Must have a Sponsor (or Sponsor/co-Sponsor pair) that has significant experience in blood cancer-relevant research.
      • The Sponsor must be the head of the laboratory where the proposed research will be performed.
      • The  Sponsor must be the PI on a nationally-awarded grant (peer-reviewed, national-level; R01-equivalent) that supports the research proposed and that extends beyond the Award start date.
      • The Sponsor must be different than the applicant’s graduate advisor and different from the head of the laboratory where the applicant’s graduate research was performed.
    • Must have a training plan for career development in blood cancer research, which is outlined in the Sponsor Letter.
    • Must propose research directly relevant to blood cancer. 
    • Must be on a clear trajectory to an independent career. 
      • In general, Special Fellow applicants must have a recent track record that is directly relevant to blood cancer.
      • In some cases, LLS and the review panel may consider Special Fellow applicants with little to no prior blood cancer experience, but there must be clear evidence of a path forward in a career in blood cancer. 
    • Must demonstrate the need for continued funding. 
  • Research must be performed in a laboratory different from where the graduate research and was performed.
  • Institution Affiliation:
    • Applicants must be affiliated with a non-profit Sponsoring Institution at the time funding commences and for the duration of the award
  • Optional Co-sponsor:
    • Applicants may have a co-Sponsor who will serve as a second mentor to their research project and career.
    • A co-Sponsor is necessary in cases whereby the applicant’s Sponsor does not have experience directly applicable to blood cancer or normal blood cell biology that has relevance to blood cancer.
    • Conversely, a co-Sponsor may provide basic scientific or technical expertise to an applicant who’s Sponsor does not have that expertise.
    • Ultimately, it is up to the applicant as to whether a co-Sponsor is needed.
  • CDP Awards support only salary.
  • Applicants may only submit one application.
    • There is a limit of one Fellow application per application cycle for each Sponsor, as well as one Special Fellow application per application cycle for each Sponsor.
    • A Sponsor may have one Fellow applicant and one Special Fellow applicant in the same application cycle.
    • There is no limit to the number of applications submitted from a specific institution, nor is there a limit to the number of Scholar applications from any Sponsor.
    • It is also acceptable for a Sponsor who currently has an active Fellow and/or Special Fellow Awardee in his/her lab to sponsor a Fellow and/or Special Fellow applicant during another award cycle

Preferences:

  • Special Fellows who have established a research program within their Sponsor’s laboratory, and who are approaching an independent career, will be most competitive.

Ineligibility:

  • No other comparable or better career development award (as measured by the total award amount) may be held prior to, or at the time of the Award start date.
    • See Other Career Development Support in the "Guidelines & Instructions" document for full details.
  • Research support requirement:
    • Research support that ends prior to the Award start date may not be used as evidence of adequate support.
    • The role of the co-Sponsor is not to provide an appropriate level of research funding support that is lacking with the primary Sponsor. If the primary Sponsor does not have adequate research funding, the applicant is not eligible. 
  • Expenditures for laboratory costs/equipment, travel, tuition, etc. are not permitted.